Select Medical Holdings Corporation (FRA:S24)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.76B -0.8% |
| Revenue (ttm) | 4.79B +5.8% |
| Net Income | 112.86M -23.2% |
| EPS | 0.93 -21.8% |
| Shares Out | n/a |
| PE Ratio | 15.56 |
| Forward PE | 12.66 |
| Dividend | 0.21 (1.54%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | n/a |
| Open | 14.00 |
| Previous Close | 13.90 |
| Day's Range | 13.90 - 14.00 |
| 52-Week Range | 9.90 - 14.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |
About Select Medical Holdings
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including reha... [Read more]
Financial Performance
In 2025, Select Medical Holdings's revenue was $5.45 billion, an increase of 5.12% compared to the previous year's $5.19 billion. Earnings were $142.87 million, a decrease of -32.52%.
Financial numbers in USD Financial StatementsNews
SEM Legal Claims: The Select Medical Board may have Breached its Fiduciary Duties to Investors – Contact BFA Law about its Pending Investigation into the Merger
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
SEM Stock Notification: Select Medical Board Investigated for Breaching its Duties to Investors Over $16.50 Acquisition Price
NEW YORK, June 2, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and s...
SEM Shareholder Notification: Select Medical $16.50 Merger Announcement Triggers Investigation into the Board on behalf of Current Shareholders – Contact BFA Law
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
$SEM Securities News: BFA Law is Investigating the Select Medical Merger – Current Shareholders are Notified to Contact the Firm
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors ...
SEM Acquisition Announcement: Select Medical Shareholders are Notified of BFA Law's Investigation into the Announced $16.50 per Share Transaction
NEW YORK--(BUSINESS WIRE)---- $SEM #Acquisition--Select Medical Shareholders are Notified of BFA Law's Investigation into the Announced $16.50 per Share Transaction.
Is $16.50 Per Share a Fair Buyout Price for Select Medical Holdings (SEM) Shareholders? Kaskela Law Encourages SEM Shareholders to Contact the Firm to Discuss Their Rights and Options to Seek Additional Compensation
NEWTOWN SQUARE, Pa., May 27, 2026 /PRNewswire/ -- Kaskela Law is investigating the recently announced proposed buyout of Select Medical Holdings Corp. (NYSE: SEM) ("Select Medical") shareholders to de...
Select Medical and Carilion Clinic form JV to operate hospital in Virginia
Select Medical (SEM) and Carilion Clinic have entered into a joint venture partnership to build and operate a new 50-bed inpatient rehabilitation hospital in Roanoke, Virginia. Select Medical will ser...
SELECT MEDICAL AND CARILION CLINIC ENTER INTO JOINT VENTURE PARTNERSHIP TO OPERATE AN INPATIENT REHABILITATION HOSPITAL IN ROANOKE, VIRGINIA
MECHANICSBURG, Pa. and ROANOKE, Va.
Select Medical Holdings Proxy statement: Proxy filing
Select Medical Holdings filed a proxy statement on May 20, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical Holdings Proxy statement: Proxy filing
Select Medical Holdings filed a proxy statement on May 15, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical downgraded to Neutral from Outperform at Mizuho
Mizuho analyst Ann Hynes downgraded Select Medical (SEM) to Neutral from Outperform with a price target of $16.50, down from $17. The company is being taken private with the deal…
Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction
SAN DIEGO--(BUSINESS WIRE)-- #SEM--Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Select Medical Holdings Corporation (NYSE: SEM) brea...
Select Medical Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw 5% revenue growth but a 6.5% decline in adjusted EBITDA, with EPS at $0.36 adjusted for transaction costs. The take-private deal is progressing, and guidance for 2026 is unchanged. Segment growth was led by inpatient rehab, while critical illness margins were pressured by Medicare Advantage denials.
Select Medical Holdings Quarterly report: Q1 2026
Select Medical Holdings has published its Q1 2026 quarterly earnings report on May 1, 2026.
Select Medical Holdings Earnings release: Q1 2026
Select Medical Holdings released its Q1 2026 earnings on May 1, 2026, summarizing the period's financial results.
Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2026 and Cash Dividend
MECHANICSBURG, Pa., April 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31...
Select Medical Holdings Corporation Announces Expiration of Hart-Scott-Rodino Waiting Period
MECHANICSBURG, Pa., April 28, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) announced today that the waiting period under the Hart-Scott...
Kaskela Law Seeks Additional Compensation for Select Medical Holdings Shareholders and Encourages Investors to Contact the Firm to Learn How to Participate
Is the buyout price of $16.50 too low? PHILADELPHIA, April 16, 2026 /PRNewswire/ -- Kaskela Law LLC is investigating the fairness of the recently announced proposed buyout of Select Medical Holdings C...
Select Medical Holdings Proxy statement: Proxy filing
Select Medical Holdings filed a proxy statement on April 15, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026
MECHANICSBURG, Pa., April 9, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2026 on T...
SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?
Kaskela Law is investigating the fairness of the $16.50 per share Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholder buyout.
Select Medical Holdings Proxy statement: Proxy Filing
Select Medical Holdings filed a proxy statement on March 4, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical Holdings Proxy statement: Proxy Filing
Select Medical Holdings filed a proxy statement on March 4, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical downgraded to Hold from Buy at Benchmark
Benchmark analyst Bill Sutherland downgraded Select Medical (SEM) to Hold from Buy with no price target after the company agreed to be acquired by a consortium led by Executive Chairman…
Select Medical downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Select Medical (SEM) to Hold from Buy with a price target of $16.50, up from $16.20, after the company agreed to be acquired by a consortium led…